NCT07005947View on ClinicalTrials.gov

Long COVID Cutaneous Signatures: An ARPA Funded Research Project

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Long COVIDAcute COVID-19Postural Orthostatic Tachycardia Syndrome (POTS)Diabetic Neuropathy

Trial Locations (1)

85258

RECRUITING

CND Life Sciences, Scottsdale

Sponsors

Lead Sponsor

CND Life Sciences

All Listed Sponsors

lead

CND Life Sciences

OTHER

NCT07005947 - Long COVID Cutaneous Signatures: An ARPA Funded Research Project | Biotech Hunter | Biotech Hunter